Full Description
| Buku Teks SO |
| Call Number | |
| Title | Orphan drugs: understanding the rare disease market and its dynamics |
| Author | Hemberg-stahl, Elizabert, author |
| Joint Author | Reljnavic, Miroslav, author |
| Publisher | Cambridge, UK: Biohealthcare Pub, 2012 |
| Subject | Orphan drugs -- Law and legislation -- United States |
| Location | Perpustakaan UI, Lantai 2 |
| Concise Text |
- Availability
- Digital Files: 0
- Review
- Cover
- Abstract
| Call Number | Barcode Number | Availability |
|---|---|---|
| 615.19 HEM o | 01-15-08250 | TERSEDIA |
| No review available for this collection: 20418963 |
Abstract
Abstract:
This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe.